The need for early international safeguards decisions impacting spent fuel storage and disposal

J. Carlson
Nuclear Materials Management. Annual Meeting Proceedings; (United States) 20

1991
PCN107 BUDGET IMPACT ANALYSIS OF LAROTRECTINIB FOR 8 TUMORS IN THE UNITED STATES

R. Hansen , T. Williamson , J. Cameron , K. Suh
Value in Health 22

2019
PCN9 VALUE OF RESEARCH ANALYSES IN RESEARCH PRIORITIZATION OF CANCER GENOMIC APPLICATIONS

J. Carlson , R. Thariani , J. Roth , S. Ramsey
Value in Health 14 ( 3) A156

1
2011
Cost-effectiveness of erlotinib vs. docetaxel or pemetrexed in the treatment of refractory non-small cell lung cancer (NSCLC)

J. Carlson , N. Oestreicher , D. P. Lubeck , S. D. Ramsey
Journal of Clinical Oncology 25 7664 -7664

4
2007
Toward Evidence-based Assessment for Coverage and Reimbursement of Laboratory-based Diagnostic and Genetic Tests

David L. Veenstra , Louis P. Garrison , Sean D. Sullivan , Rick Carlson
The American Journal of Managed Care 12 ( 4) 197 -202

33
2006
Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.

Josh Carlson , David Rind , Varun Kumar , Marita Zimmermann
Journal of Drugs in Dermatology 17 ( 7) 750 -756

14
2018
Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease.

Marita Zimmermann , Solomon J. Lubinga , Reiner Banken , David Rind
Value in Health 22 ( 2) 161 -167

25
2019
Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals.

Josh Carlson , Louis P. Garrison , Sean D. Sullivan
Journal of Managed Care Pharmacy 15 ( 8) 683 -687

44
2009
Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned

Adrian Towse , Diego Ossa , David Veenstra , Josh Carlson
Journal of Personalized Medicine 3 ( 4) 288 -305

18
2013
Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic review

Sean D. Sullivan , Rafael Alfonso-Cristancho , Josh Carlson , Usha Mallya
Journal of Medical Economics 16 ( 3) 391 -396

22
2013
Health Years in Total: A New Health Objective Function for Cost-Effectiveness Analysis.

Anirban Basu , Josh Carlson , David Veenstra
Value in Health 23 ( 1) 96 -103

4
2020